No abstract

Background Bariatric surgery depends on the development of novel anesthetic techniques to reduce the incidence of complications and improve postoperative outcomes. Ketamine and dexmedetomidine have been used for perioperative analgesia and we hypothesized that they would decrease postoperative morphine requirements. The objective of this trial is to study whether choice of ketamine or dexmedetomidine infusion would affect postoperative total morphine consumption. Methods Ninety patients were equally randomized into three groups. The ketamine group received a bolus dose (0.3 mg/kg) of ketamine over 10 min, followed by an infusion of the same drug (0.3 mg/kg/h). The dexmedetomidine group received a bolus dose (0.5 mcg/kg) of dexmedetomidine over 10 min, followed by an infusion of this drug (0.5 mg/kg/h). The control group received a saline infusion. All infusions were given till 10 min before the end of surgeries. Intraoperative fentanyl was given when patient developed hypertension and tachycardia despite adequate anesthesia and muscle relaxation. Postoperative pain was managed by a rescue dose of 4 mg of IV morphine, with a minimum interval of 6 h between morphine doses if the numerical rating scale (NRS) score was ≥ 4. The primary outcome was the total morphine dose, and the secondary outcomes were intraoperative fentanyl requirement, time to extubation, postoperative nausea and vomiting (PONV), NRS scores, and modified observer’s agitation/sedation scale (MOASS) scores. Results Compared with ketamine, dexmedetomidine decreased the need for fentanyl intraoperatively (160 ± 42 µg), shortened the time to extubation (3 ± 1 min), and improved MOASS and PONV scores. In turn, ketamine decreased postoperative NRS scores and the need for morphine (3 ± 3 mg). Conclusions Dexmedetomidine treatment was associated with lower fentanyl doses, a shorter time to extubation, and better MOASS and PONV scores. Ketamine treatment was associated with significantly lower NRS scores and morphine doses. These results indicated that dexmedetomidine effectively decreased intraoperative fentanyl requirement and the time to extubation, while ketamine decreased the need for morphine. Trial registration This trail was registered on the clinicaltrials.gov registry (NCT04576975) on October 6, 2020.

No abstract

Second-generation tyrosine kinase inhibitors (TKI), such as nilotinib and dasatinib, are used in the first-line treatment of chronic myeloid leukemia (CML), usually after the failure or resistance to imatinib. Despite a good safety profile, medications in this category have an increased incidence of specific adverse events such as pulmonary hypertension, pleural effusion, and cardiovascular/peripheral arterial events. However, renal complications are rarely reported and observed. We herein report a case of a 46-year-old patient with CML who developed nephrotic syndrome upon switching from imatinib to dasatinib therapy, with the resolution of symptoms upon treatment discontinuation and switching to nilotinib. Limited cases were reported in the literature. It is thought that the inhibition of the vascular endothelial growth factor (VEGF) pathway is the main mechanism leading to proteinuria. Dasatinib-induced nephrotic syndrome should be looked for as it can be resolved by either reducing the dose or stopping it altogether and switching to another TKI.

No abstract

Background: The development of different techniques in bariatric surgeries has required the development of novel anesthetic techniques to reduce the incidence of complications and improve post-operative patient outcomes. Ketamine and dexmedetomidine have been used for their peri-operative analgesic profiles in different studies. Methods: Ninety patients were studied and randomized equally into three groups. The Ketamine group received a bolus dose (0.3 mg/kg) of ketamine over 10 min followed by an infusion (0.3 mg/kg/h). The Dexmedetomidine group received a bolus dose (0.5 mcg/kg) of dexmedetomidine over 10 min followed by an infusion (0.5 mcg/kg/h). The control group received normal saline infusion. The total morphine dose was the primary outcome ,and intra-operative fentanyl requirements, time to extubation, post-operative nausea and vomiting (PONV), Numerical Rating Scale (NRS) scores, and Modified Observer’s Agitation/Sedation Scale (MOASS) scores were secondary outcomes of the study. Results: The Dexmedetomidine group showed decreased intra-operative fentanyl requirements (160.000 ± 42.345 µcg), less time to extubation (3.700 ± 0.925 min), and better scores on MOASS than the other groups. Post-operative NRS scores and the morphine requirement in the Ketamine group (1.867 ± 2.921 mg) were lower than in the other groups. The Dexmedetomidine group showed the lowest scores for PONV. Conclusions: The Dexmedetomidine group showed lower total fentanyl doses, a significantly shorter time to extubation, better MOASS scores, and lower PONV. The Ketamine group showed significantly lower NRS scores and morphine doses than the other two groups. Dexmedetomidine was effective on the reduction of intraoperative fentanyl requirement with early extubation, and ketamine was effective on the reduction of postoperative pain. Trial Registration: this trail has been registered on clinicaltrials.gov registry (NCT04576975) since 06/10/2020

Background Weaning from mechanical ventilation is one of the most common challenges in the intensive care unit (ICU). Most of predictive indices of weaning from mechanical ventilation are often inaccurate. This study was performed to assess the accuracy of diaphragmatic ultrasonography for predicting weaning outcome in mechanically ventilated patients with sepsis in ICU. Results Sixty patients with sepsis in medical ICU were prospectively enrolled. All patients were ventilated in pressure support. Patients underwent a spontaneous breathing trial (SBT) on T-piece when they met all the following criteria: FiO2 < 0.6, PEEP ≤5 cmH2O, PaO2/FiO2 > 200, respiratory rate <30 breaths per minute, absence of fever, alert and cooperative, hemodynamic stability without or with low-dose vasoactive therapy support, and rapid shallow breathing index (RSBI)<105. During the trial, the patient was instructed to perform deep breathing to total lung capacity (TLC) and then exhaling to residual volume (RV) and the diaphragm was visualized in the 8th or 9th intercostal space between anterior and mid-axillary lines using a 3–5-MHz curved ultrasound probe to measure diaphragmatic excursion (DE) and a 7–11-MHz linear ultrasound probe to measure diaphragmatic thickness (DT) at TLC and RV, and the diaphragmatic thickness fraction (DTF) was calculated as percentage from the following formula (thickness at end inspiration—thickness at end expiration)/thickness at end expiration. According to weaning outcome, patients were divided into 2 groups: successful weaning group and weaning failure group. Weaning failure was defined as the inability to maintain spontaneous breathing for at least 48 h, without any form of ventilatory support. In the present study, right DTF of more than 37% and DE during deep breathing of more than 6.1 and 5.4 cm on the Rt and Lt side, respectively, were associated with successful weaning from MV. In the study, the sensitivities for right and left DE and DTF were 58.33, 62.5, and 58.33%, respectively, and the pooled specificities were 83.33, 83.33, and 100%, respectively, with p value = 0.032, 0.028, and 0.001, respectively. The area under curve (AUC) for Rt, Lt DE, and DTF were 0.701, 0.712, and 0.840, respectively. The present data indicate a satisfactory diagnostic accuracy in predicting extubation outcome. Conclusions Ultrasonography-based determination of diaphragm function by assessing DTF and DE can be used as predictor of weaning outcome in mechanically ventilated patients with sepsis.

No abstract